Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

152226

Sigma-Aldrich

AEC Substrate Buffer

This AEC Substrate Buffer is validated for use in Immunoblotting and Immunohistochemistry.

Synonym(s):

AEC Substrate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41116133

Quality Level

100

form

liquid

does not contain

preservative

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

shipped in

ambient

storage temp.

2-8°C

General description

AEC Substrate Buffer is a peroxidase substrate buffer supplied as a 10X concentrate (pH 5.0 when diluted). It is used as a diluent for 3-Amino-9-ethylcarbazole (AEC), a widely used chromogen for immunohistochemical staining.

Application

AEC Substrate Buffer has been used in memory B cells enzyme-linked immune absorbent spot (ELISpot) assay.

Warning

Toxicity: Standard Handling (A)

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictograms

Corrosion
GHS05

Signal Word

Danger

Hazard Statements

H318

Precautionary Statements

P280 - P305 + P351 + P338

Hazard Classifications

Eye Dam. 1

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

152226-ML:
152226-50ML:

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Nadine G Rouphael et al.
NPJ vaccines, 6(1), 89-89 (2021-07-16)
In a phase 1 randomized, single-center clinical trial, inactivated influenza virus vaccine delivered through dissolvable microneedle patches (MNPs) was found to be safe and immunogenic. Here, we compare the humoral and cellular immunologic responses in a subset of participants receiving

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service